175 related articles for article (PubMed ID: 30146972)
1. Are treatment supporters relevant in long-term Antiretroviral Therapy (ART) adherence? Experiences from a long-term ART cohort in Uganda.
Nakamanya S; Mayanja BN; Muhumuza R; Bukenya D; Seeley J
Glob Public Health; 2019 Mar; 14(3):469-480. PubMed ID: 30146972
[TBL] [Abstract][Full Text] [Related]
2. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
Root R; Whiteside A
J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
[TBL] [Abstract][Full Text] [Related]
3. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
[TBL] [Abstract][Full Text] [Related]
4. COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.
Mayanja BN; Kasamba I; Levin J; Namakoola I; Kazooba P; Were J; Kaleebu P; Munderi P;
AIDS Res Ther; 2017; 14():26. PubMed ID: 28484508
[TBL] [Abstract][Full Text] [Related]
5. Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.
Mayanja BN; Kabunga E; Masiira B; Lubega R; Kaleebu P; Seeley J
Afr Health Sci; 2013 Jun; 13(2):311-9. PubMed ID: 24235929
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Inzaule SC; Hamers RL; Kityo C; Rinke de Wit TF; Roura M
PLoS One; 2016; 11(11):e0167492. PubMed ID: 27898736
[TBL] [Abstract][Full Text] [Related]
7. Barriers to HIV Treatment Adherence: A Qualitative Study of Discrepancies Between Perceptions of Patients and Health Providers in Tanzania and Uganda.
Moucheraud C; Stern AF; Ahearn C; Ismail A; Nsubuga-Nyombi T; Ngonyani MM; Mvungi J; Ssensamba J
AIDS Patient Care STDS; 2019 Sep; 33(9):406-413. PubMed ID: 31517526
[TBL] [Abstract][Full Text] [Related]
8. Habit formation in support of antiretroviral medication adherence in clinic-enrolled HIV-infected adults: a qualitative assessment using free-listing and unstructured interviewing in Kampala, Uganda.
Jennings Mayo-Wilson L; Devoto B; Coleman J; Mukasa B; Shelton A; MacCarthy S; Saya U; Chemusto H; Linnemayr S
AIDS Res Ther; 2020 Jun; 17(1):30. PubMed ID: 32513192
[TBL] [Abstract][Full Text] [Related]
9. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
[TBL] [Abstract][Full Text] [Related]
10. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.
Ware NC; Wyatt MA; Pisarski EE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Bangsberg DR; Haberer JE;
AIDS Behav; 2020 Sep; 24(9):2624-2636. PubMed ID: 32140877
[TBL] [Abstract][Full Text] [Related]
11. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.
Denison JA; Koole O; Tsui S; Menten J; Torpey K; van Praag E; Mukadi YD; Colebunders R; Auld AF; Agolory S; Kaplan JE; Mulenga M; Kwesigabo GP; Wabwire-Mangen F; Bangsberg DR
AIDS; 2015 Jan; 29(3):361-71. PubMed ID: 25686684
[TBL] [Abstract][Full Text] [Related]
12. Finding Meaning: HIV Self-Management and Wellbeing among People Taking Antiretroviral Therapy in Uganda.
Russell S; Martin F; Zalwango F; Namukwaya S; Nalugya R; Muhumuza R; Katongole J; Seeley J
PLoS One; 2016; 11(1):e0147896. PubMed ID: 26807932
[TBL] [Abstract][Full Text] [Related]
13. The role of social support on HIV testing and treatment adherence: A qualitative study of HIV-infected refugees in southwestern Uganda.
Rouhani SA; O'Laughlin KN; Faustin ZM; Tsai AC; Kasozi J; Ware NC
Glob Public Health; 2017 Aug; 12(8):1051-1064. PubMed ID: 26783835
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting the Implementation of Electronic Antiretroviral Therapy Adherence Monitoring and Associated Interventions for Routine HIV Care in Uganda: Qualitative Study.
Haberer JE; Garrison L; Tumuhairwe JB; Baijuka R; Tindimwebwa E; Tinkamanyire J; Burns BF; Asiimwe S
J Med Internet Res; 2020 Sep; 22(9):e18038. PubMed ID: 32687473
[TBL] [Abstract][Full Text] [Related]
15. Adherence to antiretroviral and cancer chemotherapy, and associated factors among patients with HIV-cancer co-morbidity at the Uganda Cancer Institute: a cross sectional study.
Achieng C; Bunani N; Kagaayi J; Nuwaha F
BMC Public Health; 2023 Jul; 23(1):1451. PubMed ID: 37507710
[TBL] [Abstract][Full Text] [Related]
16. "How am I going to live?": exploring barriers to ART adherence among adolescents and young adults living with HIV in Uganda.
MacCarthy S; Saya U; Samba C; Birungi J; Okoboi S; Linnemayr S
BMC Public Health; 2018 Oct; 18(1):1158. PubMed ID: 30286746
[TBL] [Abstract][Full Text] [Related]
17. Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross-sectional population-based study.
Kennedy CE; Feng X; Ssekubugu R; Rosen JG; Ssekasanvu J; Kigozi G; Serwadda D; Yeh PT; Kagaayi J; Quinn TC; Tobian AAR; Wawer MJ; Reynolds SJ; Chang LW; Grabowski MK; Nalugoda F
J Int AIDS Soc; 2023 Sep; 26(9):e26135. PubMed ID: 37705364
[TBL] [Abstract][Full Text] [Related]
18. Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults.
Duwell MM; Knowlton AR; Nachega JB; Efron A; Goliath R; Morroni C; Maartens G; Chaisson RE
AIDS Patient Care STDS; 2013 Feb; 27(2):96-102. PubMed ID: 23373664
[TBL] [Abstract][Full Text] [Related]
19. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
[TBL] [Abstract][Full Text] [Related]
20. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
